Diabetes Type II - Comparison between Olanzapine and Risperidone (CROSBI ID 209592)
Prilog u časopisu | izvorni znanstveni rad | međunarodna recenzija
Podaci o odgovornosti
Filaković, Pavo ; Koić, Oliver ; Laufer, Davor ; Radanović-Grgurić, Ljiljana ; Degmečić, Dunja ; Požgain, Ivan
engleski
Diabetes Type II - Comparison between Olanzapine and Risperidone
Differences in the glucose metabolism were examined in this study between patient treated with olansapine and risperidone in comparison with healthy volunteers. Authors conclude that insuline resistence is the main mechanism for development of diabetes type II in the schizophrenic patients treated with antipsychotics.
schizophrenia ; secong generation antipsychotics ; glucose metabolism
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
nije evidentirano
Podaci o izdanju
Povezanost rada
Kliničke medicinske znanosti